Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

Article Details

Citation

Copy to clipboard

Gunes A, Dahl ML

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

Pharmacogenomics. 2008 May;9(5):625-37. doi: 10.2217/14622416.9.5.625.

PubMed ID

18466106 [ View in PubMed

]

Abstract

CYP1A2 is involved in the metabolism of several widely used drugs and endogenous compounds, and in the activation of procarcinogens. Both genetic and environmental factors influence the activity of this enzyme. The current knowledge regarding factors influencing the activity of CYP1A2 is summarized in this review. Substrates, inhibitors and inducers of CYP1A2 activity, as well as phenotyping probes, are discussed. The functional significance and clinical importance of CYP1A2 gene polymorphisms are reviewed and interethnic differences in the distribution of CYP1A2 variant alleles and haplotypes are summarized. Finally, future perspectives for the possible clinical applications of CYP1A2 genotyping are discussed.

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Flumequine	Cytochrome P450 1A2	Protein	Humans	Unknown	Inhibitor	Details